{"id":"W2898861270","doi":"10.15252/emmm.201809172","title":"A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation","year":2018,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Université Laval; Centre hospitalier de l'Université Laval","funders":"Instituto de Salud Carlos III; European Society for Medical Oncology; Canadian HIV Trials Network, Canadian Institutes of Health Research; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Cancer Research UK; Generalitat de Catalunya; Fundación Científica Asociación Española Contra el Cáncer; Fundación Cellex; AstraZeneca","keywords":"Mutation; Molecular biology; Poly ADP ribose polymerase; Chemistry; Biology; Cancer research; Genetics; DNA; Gene; Polymerase","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001664942,0.0007500816,0.0005743116,0.002277985,0.0002261828,0.0007863955,0.000325713,0.0007730721,0.003778097],"category_scores_gemma":[0.002063031,0.0002979357,0.0003718488,0.001115469,0.0003997878,0.000352227,0.0003082508,0.0007092904,0.001846255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002432539,"about_ca_system_score_gemma":0.0001660505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003564516,"about_ca_topic_score_gemma":0.0007439474,"domain_scores_codex":[0.9987876,0.0003456426,0.0001538214,0.0003602765,0.0002677141,0.00008501777],"domain_scores_gemma":[0.9984257,0.0006313355,0.0003452983,0.00022917,0.0002733301,0.00009521257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001480438,0.0001928152,0.2515239,0.0003368988,0.0001770346,0.0004149942,0.0001370804,0.0006201554,0.6989443,0.0004604472,0.001447457,0.04426447],"study_design_scores_gemma":[0.0000403021,0.001253089,0.4993733,0.00005713915,0.000209796,0.003268855,0.0001469295,0.004722523,0.4818901,0.0005392223,0.008459321,0.00003932742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9421991,0.007601177,0.03323333,0.000352354,0.0002169778,0.0002610874,0.003829526,0.001145614,0.01116078],"genre_scores_gemma":[0.9655902,0.001839123,0.02568135,0.0002503645,0.00005745985,0.0001567523,0.002978597,0.00009707523,0.003349068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003778097,"threshold_uncertainty_score":0.01263899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02386045222621364,"score_gpt":0.3273131591371021,"score_spread":0.3034527069108885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}